Analysis of PROKR2 gene mutation in patients with hypogonadotropic hypogonadism
10.3760/cma.j.cn112138-20210821-00571
- VernacularTitle:低促性腺激素性性腺功能减退症患者PROKR2基因突变分析
- Author:
Yidan XIE
1
;
Ruizhi ZHENG
;
Binbin HAN
;
Huijuan YUAN
;
Jiada LI
Author Information
1. 河南大学人民医院（河南省人民医院）内分泌科，郑州450003
- Keywords:
Hypogonadism;
Idiopathic hypogonadotropicm;
PROKR2 gene;
Mutation
- From:
Chinese Journal of Internal Medicine
2022;61(8):933-936
- CountryChina
- Language:Chinese
-
Abstract:
To investigate the clinical and genetic characteristics of patients with idiopathic hypogonadotropic hypogonadism (IHH), the clinical data of 23 patients with IHH were retrospectively analyzed. Gene analyses were accomplished with whole-exome sequencing (WES) and Sanger sequencing. Functional prediction of mutation sites was conducted using two bioinformatics platforms, SIFT and Polyphen. Among the 23 patients with IHH, 9 patients carried prokinin 2 (PROKR2) gene mutations including 4 missense mutations (p.W178S, p.Y113H, p.A103V, p.R164Q), and 1 frameshift mutation (p.D42delinsDED), the remaining 14 cases were found negative in gene sequencing. Functional prediction showed that the above mutations may affect protein function suggestive of a pathogenic role of PROKR2 mutation in the patients. There were no significant differences in the levels of follicle-stimulating hormone, luteinizing hormone, testosterone, and estradiol between the IHH patients with PROKR2 gene mutation and those without. PROKR2 gene mutation might associated with IHH, and the mutations reported in the present study could enrich the pathogenic spectrum of genes.
